← back to search

V. Diana

Anna Needs Neuroblastoma Answers · US
Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Retinal Diseases and Treatments, Ocular Diseases and Behçet’s Syndrome, Retinal and Optic Conditions, and Retinal Imaging and Analysis.
h-index
42
citations
7,043
works
204
NIH funding
primary concept
email

Recent publications

TARGETED INTERVENTIONS LEAD TO QUALITY IMPROVEMENT IN YEAR 2 OF AN ARTIFICIAL INTELLIGENCE-BASED DIABETIC RETINOPATHY DETECTION PROGRAM IN NORTHERN CALIFORNIA
Retina 2025cited by 1position: middledoi
Analysis of full-field electroretinography parameters and potential for monitoring functional retinal deterioration in unilateral retinal vasculitis.
2025cited by 0position: contributordoi
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy
Eye 2024cited by 13position: middledoi
Utilisation of composite endpoint outcome to assess efficacy of tocilizumab for non-infectious uveitis in the STOP-Uveitis Study.
2023cited by 7position: contributordoi
Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?
Expert Opinion on Biological Therapy 2022cited by 78position: middledoi
Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context.
2022cited by 3position: contributordoi
Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema
International Journal of Retina and Vitreous 2019cited by 21position: middledoi
SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS
Retina 2018cited by 74position: middledoi
Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis
Ophthalmology 2018cited by 34position: lastdoi
Intravitreal Aflibercept for Diabetic Macular Edema
Ophthalmology 2016cited by 418position: middledoi
Intravitreal Aflibercept for Diabetic Macular Edema
Ophthalmology 2015cited by 614position: middledoi
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
Ophthalmology 2012cited by 393position: firstdoi
Ranibizumab for Edema of the Macula in Diabetes Study
JAMA Ophthalmology 2012cited by 151position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Quan Dong Nguyen · Smith-Kettlewell Eye Research Institute7 papers (2012–2022)David M. Brown · Tennessee Retina4 papers (2012–2019) · 3 papers (2012–2016) · 3 papers (2022–2025)Ursula Schmidt‐Erfurth · Medical University of Vienna3 papers (2012–2016)David S. Boyer · University of Southern California3 papers (2012–2016) · 3 papers (2012–2016)Oliver Zeitz · Charité - Universitätsmedizin Berlin3 papers (2012–2016) · 3 papers (2012–2016)Dennis M. Marcus · Augusta University2 papers (2015–2016)Glenn J. Jaffe · Duke University2 papers (2015–2016)Carola Metzig · Bayer (Germany)2 papers (2015–2016)Yasir J. Sepah · Palo Alto University2 papers (2018–2019)Frank G. Holz · Tsinghua University2 papers (2015–2016)Peter K. Kaiser · Cleveland Clinic2 papers (2015–2016)Yuhwen Soo · Regeneron (United States)2 papers (2015–2016)Jeffrey S. Heier · Wills Eye Hospital2 papers (2015–2016)Edoardo Midena · University of Padua2 papers (2015–2016) · 2 papers (2015–2016)Jason S. Slakter · NYU Langone Health2 papers (2015–2016)